Table 1.

Patient characteristics

Patient	Gender	Age (years)	Staging	Histology	Smoking history	Driver mutation	Tumor size (cm)	Tumor location	Underlying pulmonary diseases
1	Male	74	IIA	Lung adenocarcinoma	Non-smoker		4.5	Peripheral
2	Male	72	IA	Lung adenocarcinoma	Non-smoker	EGFR (p.Glu746_Ala750del)	1.6	Peripheral	History of community-acquired pneumonia 18 months prior to NSCLC diagnosis
3	Female	71	IA	Lung adenocarcinoma	Non-smoker	EGFR (p.Glu746_Ala750del)	2	Peripheral
4	Female	60	IA	Lung adenocarcinoma	Smoker	BRAF (p.Val600Glu)	2	Peripheral
5	Male	69	IA	Lung adenocarcinoma	Non-smoker	EGFR (p.Glu746_Ala750del)	3	Peripheral
6	Male	62	IA	Lung squamous cell carcinoma	Smoker		3	Peripheral
7	Male	50	IA	Lung squamous cell carcinoma	Smoker		1.2	Peripheral
8	Female	66	Limited stage	Small cell lung cancer	Non-smoker		1.5	Peripheral
9	Male	56	IA	Lung adenocarcinoma	Non-smoker	EGFR (p.Glu746_Ala750del)	1.8	Peripheral	Pulmonary embolism
10	Female	68	IA	Lung adenocarcinoma	Smoker	KRAS (p.Gly12Cys)	2.8	Peripheral	COPD
11	Female	78	IA	Lung adenocarcinoma	Non-smoker	EGFR (p.Leu858Arg)	1.6	Peripheral
12	Male	58	IIB	Lung squamous cell carcinoma	Smoker		3.5	Central	COPD

COPD, chronic obstructive pulmonary disease; NSCLC, non-small cell lung cancer.